LifeStance Health Group, Inc. reported earnings results for the second quarter and six months ended June 30, 2023. For the second quarter, the company reported sales was USD 259.58 million compared to USD 209.53 million a year ago. Net loss was USD 45.48 million compared to USD 68.73 million a year ago. Basic loss per share from continuing operations was USD 0.13 compared to USD 0.19 a year ago.
For the six months, sales was USD 512.17 million compared to USD 412.62 million a year ago. Net loss was USD 79.72 million compared to USD 131.06 million a year ago. Basic loss per share from continuing operations was USD 0.22 compared to USD 0.37 a year ago.